May 11, 2022 / 04:20PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good morning, everyone. I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst, and joining my colleague, Mike Ryskin. Welcome to Bank of America's 2022 Healthcare Conference live from Las Vegas. It's a pleasure to introduce our next company, Thermo Fisher Scientific with Marc Casper, Chairman, President and CEO.
I've covered Thermo since 2003, which is about the same time that Marc got there, so we've been going back a long ways. And wow, what a difference 20 years makes in terms of looking at the company. I think it was $20 and $4 billion in market cap when I picked up this coverage of the stock years ago. So a long way from then.
Marc, you want to start off just -- you had a -- you put up -- reported Q1 results a couple of weeks ago. Really just had a strong result on that. You want to talk about sort of what's going on there? I mean, 16% core growth, well above everybody's expectations. Can you sort of set the stage for us at all?
Marc N. Casper - Thermo
Thermo Fisher Scientific Inc at Bank of America Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers